VKTX

Viking Therapeutics, Inc.NASDAQ

24.706 USDT+2.02%Bitget perpetual · refreshed every 30s

24h value$271.6KOpen interest$112.6KFunding0.0000%vikingtherapeutics.com ↗

Key filings

Earnings, material events (8-K), quarterly and annual reports, ownership reports

2026-09-288-KMaterial event report · Material agreement, New financial obligationSource ↗
2026-09-228-KMaterial event report · Other eventsSource ↗
2026-07-30S-3ASRShelf registrationSource ↗
2026-07-2910-QQuarterly reportSource ↗
2026-07-298-KMaterial event report · Earnings releaseSource ↗
2026-05-268-KMaterial event report · Shareholder vote resultsSource ↗
2026-04-30SCHEDULE 13G5%+ ownership (passive)Source ↗
2026-04-3010-QQuarterly reportSource ↗
2026-04-298-KMaterial event report · Earnings releaseSource ↗
2026-04-01DEF 14AProxy statementSource ↗
2026-03-27SCHEDULE 13G/A5%+ ownership (passive) (Amended)Source ↗
2026-02-1110-KAnnual reportSource ↗
2026-02-118-KMaterial event report · Earnings releaseSource ↗
2025-11-05SCHEDULE 13G/A5%+ ownership (passive) (Amended)Source ↗
2025-10-2310-QQuarterly reportSource ↗

Filings are in English. Form and item labels are only a classification to help you navigate and do not interpret the filing.

Stock transactions by officers and major holders (Form 4) and notices of proposed sale (Form 144)